In the News: Trial First to Show Improvements in Alzheimer’s Patients

Pharmaceutical trials for Alzheimer’s have failed repeatedly, but a new study, using a fundamentally different approach, has provided the first success: using precision medicine to identify and target the drivers of Alzheimer’s or pre-Alzheimer’s in each patient, a team of physicians and researchers has posted exciting, positive results in medRxiv, the Yale-backed site for health sciences.

Alzheimers trial 1 alzheimers trial 2